First-Line Penpulimab Combined With Paclitaxel and Carboplatin for Treating Patients With Metastatic Squamous NSCLC
Sign in to PracticeUpdate
Only registered members have full access to PracticeUpdate content.
Additional Info
Disclosure statements are available on the authors' profiles:
The Lancet Respiratory Medicine
From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.
First-line penpulimab combined with paclitaxel and carboplatin for metastatic squamous non-small-cell lung cancer in China (AK105-302): a multicentre, randomised, double-blind, placebo-controlled phase 3 clinical trial
Lancet Respir Med 2024 Jan 31;[EPub Ahead of Print], H Zhong, S Sun, J Chen, Z Wang, Y Zhao, G Zhang, G Chen, M Zhou, J Zhou, Y Du, L Wu, Z Xu, X Mei, W Zhang, J He, J Cui, Z Zhang, H Luo, W Liu, M Sun, J Wu, Y Shen, S Zhang, N Yang, M Wang, J Lu, K Li, W Yao, Q Sun, H Yue, L Wang, S Ye, B Li, X Zhuang, Y Pan, M Zhang, Y Shu, Z He, L Pan, Y Ling, S Liu, Q Zhang, S Jiao, B HanFrom MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.